The Enterprise Value as of April 2026 (TTM) for Reviva Pharmaceuticals Holdings, Inc. (RVPH) is -14031914107365.00

According to Reviva Pharmaceuticals Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -14031914107365.00. This represents a change of 300.00% compared to the average of -3507958267788.29 of the last 4 quarters.

Reviva Pharmaceuticals Holdings, Inc. (RVPH) Historical Enterprise Value (quarterly & annually)

How has RVPH Enterprise Value performed in the past?

The mean historical Enterprise Value of Reviva Pharmaceuticals Holdings, Inc. over the last ten years is -1753950195077.75. The current -14031914107365.00 Enterprise Value has changed 79.90% with respect to the historical average. Over the past ten years (40 quarters), RVPH's Enterprise Value was at its highest in in the June 2023 quarter at 120.54M. The Enterprise Value was at its lowest in in the December 2025 quarter at -14031896755760.00.

Reviva Pharmaceuticals Holdings, Inc. (RVPH) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Reviva Pharmaceuticals Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Reviva Pharmaceuticals Holdings, Inc. (RVPH) Average Enterprise Value

How has RVPH Enterprise Value performed in the past?

The current Enterprise Value of Reviva Pharmaceuticals Holdings, Inc. (RVPH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Reviva Pharmaceuticals Holdings, Inc. (RVPH) Enterprise Value vs. Peers

How is RVPH’s Enterprise Value compared to its peers?

Reviva Pharmaceuticals Holdings, Inc.’s Enterprise Value is less than Annovis Bio, Inc. (-19494466291.00), less than PolyPid Ltd. (42.25M), less than Celularity Inc. (89.85M), less than BioAtla, Inc. (4.05M), less than Actinium Pharmaceuticals, Inc. (-10693382.00), less than Evaxion Biotech A/S (11.19M), less than PDS Biotechnology Corporation (5.22B), less than BioXcel Therapeutics, Inc. (111.91M), less than Tvardi Therapeutics, Inc. (9.30M), less than FibroGen, Inc. (-19179975.00),

Build a custom stock screener for Reviva Pharmaceuticals Holdings, Inc. (RVPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Reviva Pharmaceuticals Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Reviva Pharmaceuticals Holdings, Inc. (RVPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Reviva Pharmaceuticals Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.